Allergan Clashes With Buyers Over Cert. Bid In Antitrust MDL
By Khorri Atkinson ( October 16, 2019, 7:20 PM EDT) -- A group of direct Allergan buyers seeking to pursue a class action over a delayed rollout of a cheaper generic version of the drugmaker's dry-eye medication Restasis traded barbs with the company Tuesday over how the litigation should proceed....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.